The impact of semaglutide on wound healing in diabetes related foot ulcer patients: A TriNetX database study

被引:0
|
作者
Lewis, Joshua E. [1 ]
Omenge, Diana K. [2 ]
Patterson, Amani R. [1 ]
Anwaegbu, Ogechukwu [1 ]
Tabukum, Nangah N. [1 ]
Lewis III, Jimmie E. [3 ]
Lee, Wei-Chen [4 ]
机构
[1] Univ Texas Med Branch, John Sealy Sch Med, Galveston, TX USA
[2] Univ Houston, Tilman J Fertitta Coll Med, Sch Med, Houston, TX USA
[3] Barry Univ, Sch Podiatr Med, Miami, FL USA
[4] Univ Texas Med Branch, Dept Family Med, 301 Univ Blvd, Galveston, TX 77555 USA
来源
DIABETES & VASCULAR DISEASE RESEARCH | 2025年 / 22卷 / 02期
关键词
Diabetes related foot ulcers; semaglutide; GLP-1 receptor agonists; wound healing; diabetes complications; CHALLENGES;
D O I
10.1177/14791641251322909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Diabetes related foot ulcers (DFUs) are common complications of type 2 diabetes mellitus (T2DM), affecting 15-25% of individuals living with diabetes and significantly contributing to healthcare costs ($9-13 billion annually in the U.S.). Without effective management, these wounds often lead to severe outcomes like amputations. This study aims to examine the association of semaglutide on DFU management. Methods: This retrospective cohort study utilized TriNetX US Research Network data to assess the impact of semaglutide, a GLP-1 receptor agonist, on DFU outcomes between 2013 and 2023. The study compared outcomes between semaglutide users with DFU (Cohort A, N = 6329) and non-users with DFU (Cohort B, N = 118,821) across 64 healthcare organizations. We matched participants by age, gender, race, and ethnicity; however, we excluded patients with certain co-morbidities. Statistical analysis, such as chi-square analysis and risk ratio, using TriNetX software evaluated different complication outcomes. Results: Semaglutide users with DFU demonstrated lower relative risks for complications compared to non-users. Within 1 year, semaglutide users were associated with lower relative risks for wound healing complications (0.19% vs 0.38%), chronic non-healing wounds (0.75% vs 1.23%), chronic pain (4.44% vs 8.06%), wound care (2.42% vs 4.86%), wound dehiscence (0.26% vs 0.56%), and amputation (2.34% vs 5.21%) (p < .05). Similar trends persisted over 5 years. While these findings highlight potential benefits of semaglutide with patients with DFU, causation cannot be inferred due to the study's observational design. Conclusion: Semaglutide use was associated with favorable outcomes in patients with diabetes-related foot ulcers, including reductions in wound-related complications. While these findings suggest potential benefits of semaglutide as an adjunct in DFU management, further research is needed to confirm these associations and to better understand the mechanisms involved.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Topical propolis improves wound healing in patients with diabetic foot ulcer: a randomized controlled trial
    Afkhamizadeh, Mozhgan
    Aboutorabi, Robab
    Ravari, Hassan
    Najafi, Mohsen Fathi
    Azimi, Sajad Ataei
    Langaroodi, Adineh Javadian
    Yaghoubi, Mohammad Ali
    Sahebkar, Amirhossein
    NATURAL PRODUCT RESEARCH, 2018, 32 (17) : 2096 - 2099
  • [22] Efficacy of collagen based biomaterials in diabetic foot ulcer wound healing
    Khatoon, Fareeda
    Narula, A. K.
    Sehgal, Preeti
    EUROPEAN POLYMER JOURNAL, 2024, 217
  • [23] Changes in miroRNA-103 expression in wound margin tissue are related to wound healing of diabetes foot ulcers
    Zhao, Xiaotong
    Xu, Murong
    Tang, Ying
    Xie, Dandan
    Wang, Youmin
    Chen, Mingwei
    INTERNATIONAL WOUND JOURNAL, 2023, 20 (02) : 467 - 483
  • [24] A Predictive Model for Diabetic Foot Ulcer Outcome: The Wound Healing Index
    Fife, Caroline E.
    Horn, Susan D.
    Smout, Randall J.
    Barrett, Ryan S.
    Thomson, Brett
    ADVANCES IN WOUND CARE, 2016, 5 (07) : 279 - 287
  • [25] Proteomic Analysis of Diabetic Foot Ulcer Fluid to Identify Biomarkers of Wound Healing: A Prospective Study
    Vatankhah, Nasibeh
    Jalili, Vahid
    Jahangiri, Younes
    DIABETES, 2021, 70
  • [26] The Effect of Individualised Glycemic Intervention on Wound Healing Rate in Diabetic Foot Ulcer (The EIGIFU Study)
    Lim, Kim Piow
    Nasruddi, Azraai Bahari
    Rani, Noraishah Md
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2018, 33 (01): : 22 - 27
  • [27] Effects of diabetes-related foot ulcer depth on healing days, cost, and quality of life: A prospective observational study
    Oe, Makoto
    Jais, Suriadi
    Sari, Nurmila
    Sanada, Hiromi
    Sasongko, Agung
    Haryanto, Haryanto
    HEALTH SCIENCE REPORTS, 2024, 7 (08)
  • [28] Wound healing and healing process in patients with diabetic foot ulcers: A survival analysis study
    Pereira, M. Graca
    Vilaca, Margarida
    Pedras, Susana
    Carvalho, Andre
    Vedhara, Kavita
    Dantas, M. Jesus
    Machado, Luis
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [29] Sequencing of messenger RNA in the healing process of diabetes foot ulcer
    Wang, Guili
    Wu, Ding
    Lu, Donglin
    Wu, Huifang
    Cai, Yunmin
    Meng, Qingyi
    Liu, Zhaoxuan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [30] Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study
    Able, Corey
    Liao, Brian
    Saffati, Gal
    Maremanda, Ankith
    Applewhite, James
    Nasrallah, Ali A.
    Sonstein, Joseph
    Alzweri, Laith
    Kohn, Taylor P.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2024, : 315 - 319